6 Sept 2026
Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agentsPublisher siteFuture Medicinal Chemistry, Angiogenesis and VEGF in Cancer
Active, last published 2026
In synthesis and biological activity
Dalal Z.
Husein
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Claim Your Profile24
H-index
2.1k
Citations
Dalal has not officially claimed their profile. If you are Dalal, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
alal Z. Husein is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Dalal's work has been cited 2,064 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×43Angiogenesis and VEGF in Cancer×27Bioactive Compounds and Antitumor Agents×18Click Chemistry and Applications×13HER2/EGFR in Cancer Research×12
04 · Where I am
Affiliations
Affiliation on published researchNile Valley University, SudanDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
33 works26 Aug 2026
Rational design of a bis-acetanilide hydrazone–thiourea hybrid as a potent VEGFR-2 inhibitor: in silico and in vitro evaluationsPublisher siteChemical Papers, Angiogenesis and VEGF in Cancer
1 May 2026
Structure‐Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor‐2 Inhibitors With Potent Anticancer ActivityPublisher siteDrug Development Research, Angiogenesis and VEGF in Cancer
1 Mar 2026
Thiadiazole‐Derived <scp>VEGFR</scp> ‐2 Inhibitors: From Design to Anticancer EvaluationPublisher siteChemical Biology & Drug Design, Angiogenesis and VEGF in Cancer
18 Nov 20251cites
2,3-Dihydro-1,3,4-thiadiazoles as dual B-Raf / VEGFR-2 inhibitors: Design, synthesis, and anti-breast cancer assessmentPublisher siteJournal of Molecular Structure
24 Oct 20252cites
Design, Computational, Synthesis, and Anti-Cancer Evaluation of a Multifunctional 2,3-Dihydro-1,3,4-Thiadiazole-Benzenesulfonamide Hybrid as a Triple Inhibitor of CAIX, CAXII, and EGFRPublisher siteJournal of Computational Biophysics and Chemistry, Enzyme function and inhibition
1 Oct 20254cites
Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFRPublisher siteCurrent Cancer Drug Targets, Quinazolinone synthesis and applications
4 Sept 2025Open access2cites
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyPublisher sitePLoS ONE, Enzyme function and inhibition
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Dalal?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you